Has Ryan Oakley received payments from drug or device companies?

Yes. Drug and device makers reported $1,950 in general payments to Ryan Oakley across 89 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ryan Oakley did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ryan Oakley come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ryan Oakley

Psychiatry · Nashville, TNNPI 1215434501

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $938, 8.6 times the $109 reported in 2022.

$1,950in general payments, 2019–2025

Across 89 payments — averaging $21.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Livanova USA, Inc.$265
Axsome Therapeutics, Inc.$244
Alkermes, Inc.$233
Johnson & Johnson$218
AbbVie$192
Takeda Pharmaceuticals U.S.A., Inc.$163
plus $635 from 12 others

What the payments were for

Food & beverage$1,950100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Livanova USA, Inc.	2	$265
Axsome Therapeutics, Inc.	11	$244
Alkermes, Inc.	11	$233
Johnson & Johnson	13	$218
AbbVie	9	$192
Takeda Pharmaceuticals U.S.A., Inc.	9	$163
Supernus Pharmaceuticals, Inc.	6	$110
Vanda Pharmaceuticals Inc.	5	$105
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	6	$102
Otsuka America Pharmaceutical, Inc.	4	$73
Noven Therapeutics, LLC	4	$61
Neurocrine Biosciences, Inc.	2	$46
Tempus AI, Inc	2	$33
E.r. Squibb & Sons, L.L.C.	1	$29
Sunovion Pharmaceuticals Inc.	1	$23
Lundbeck LLC	1	$23
Dentsply Sirona Inc	1	$16
Idorsia Pharmaceuticals US Inc	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VNS Therapy Symmetry Model 8103 Generator$265

How this compares

$1,950 in reported general payments places this provider in the 75th percentile of 503 psychiatry providers in Tennessee.

See all psychiatry providers in Tennessee →

Other psychiatry in Nashville

Rakesh AminNashville$3M
Robert JamiesonNashville$141K
Michelle CochranNashville$74K
Amanda Sparks-BushnellNashville$66K
Craig ClarkNashville$31K
Joseph SharpeNashville$29K
Colleen FriddellNashville$23K
Jane WeinbergNashville$22K
Esiri EsinNashville$18K
Tianlai TangNashville$11K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →